| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/01/2006 | EP1347971B1 Thiazolyl inhibitors of tec family tyrosine kinases |
| 03/01/2006 | EP1324774B1 Use of a ppar delta activator for treating inflammatory conditions |
| 03/01/2006 | EP1319007B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/01/2006 | EP1311507B1 Fused pyrazole derivatives being protein kinase inhibitors |
| 03/01/2006 | EP1239875B1 Use of staphylococcal bacteria to treat irritable bowel syndrome |
| 03/01/2006 | EP1206471B1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 03/01/2006 | EP1133285B1 A process for producing particles with a converted amorphous and/or meta-stable crystalline region into crystalline state |
| 03/01/2006 | EP1105409B1 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 03/01/2006 | EP1067927B1 Antioxidant stabilizer system for pharmaceutical formulations |
| 03/01/2006 | EP1017382B1 Biarylalkanoic acids as cell adhesion inhibitors |
| 03/01/2006 | CN1742082A Primitive and proximal hepatic stem cells |
| 03/01/2006 | CN1742013A Pyrazolopyrimidine compound and method for producing the same |
| 03/01/2006 | CN1741990A Arylalkylcarbamate derivatives production and use thereof in therapy |
| 03/01/2006 | CN1741820A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/01/2006 | CN1741807A Anticulcer herbal composition(s) |
| 03/01/2006 | CN1741749A Nutritional compositions |
| 03/01/2006 | CN1740315A A transgenic mouse liver disease animal model producing process and application thereof |
| 03/01/2006 | CN1739802A Method of producing hepatitis B vaccine in non-human mammal mammary gland as bioreactor |
| 03/01/2006 | CN1739794A Thymosin alpha-1 aqua prepn and its prepn process and application |
| 03/01/2006 | CN1739789A Somatostation a aqua prepn and its prepn process and application |
| 03/01/2006 | CN1739786A Thymic pentapeptide aqua prepn and its prepn process and application |
| 03/01/2006 | CN1739783A Chinese medicine composition for treating gastritis, gastric ulcer and duodenal ulcer |
| 03/01/2006 | CN1739781A Medicine composite for treating hyperlipemia and its prepn |
| 03/01/2006 | CN1739773A Cholelithiasis treating medicine and its prepn |
| 03/01/2006 | CN1739768A Pain treating Chinese medicine and its prepn |
| 03/01/2006 | CN1739767A Compound recipe capable of protecting liver and improving symptoms of hepatosis |
| 03/01/2006 | CN1739760A Stomach-benefiting medicine and its prepn |
| 03/01/2006 | CN1739758A Chinese medicine composition for treating digestive system ulcer |
| 03/01/2006 | CN1739751A Chinese medicine prepn for invigorating spleen and benefiting vital energy and its prepn process and quality control method |
| 03/01/2006 | CN1739739A Chinese medicine prepn for treating ulcer and its prepn process and quality control method |
| 03/01/2006 | CN1739735A Chinese medicine effective part composition |
| 03/01/2006 | CN1739734A Chinese medicine prepn for treating stomatitis and its prepn process |
| 03/01/2006 | CN1739718A Kidney invigorating yurong oral liquid and its prepn |
| 03/01/2006 | CN1739717A Medicine for treating chronic gastropathy and its prepn |
| 03/01/2006 | CN1739715A Chinese medicine prepn for nourishing kidney and liver and its prepn process |
| 03/01/2006 | CN1739714A Chinese medicine prepn of invigorating kidney and benefiting vital energy and its prepn process and quality control method |
| 03/01/2006 | CN1739706A Tongue dropping medicine pill for diminishing inflammation and detoxicating |
| 03/01/2006 | CN1739680A Chinese medicine for treating internal hemorrhage and its prepn process |
| 03/01/2006 | CN1739668A Transaminase lowering dripping pill and its prepn |
| 03/01/2006 | CN1739659A Medicine composition for treating hepatosis and its prepn |
| 03/01/2006 | CN1739653A Chinese medicine prepn for soothing the liver and alleviating mental depression and its prepn process and quality control method |
| 03/01/2006 | CN1739650A Cappillary artemisia-cape jasmine-rhubarb soft capsule and its prepn process |
| 03/01/2006 | CN1739631A Fengliao Changweikang soft capsule and its prepn |
| 03/01/2006 | CN1739615A Chinese medicine for treating peptic ulcer and its prepn process |
| 03/01/2006 | CN1739614A Component detecting method of Weiteling capsule |
| 03/01/2006 | CN1739604A Antiphlogistic gallbladder-benefiting dripping pill and its prepn process |
| 03/01/2006 | CN1739603A Antiphlogistic gallbladder-benefiting soft capsule and its prepn process |
| 03/01/2006 | CN1739602A Technological process of extracting effective hepatitis resisting component from Halenia comiculata plant |
| 03/01/2006 | CN1739599A Blood fat reducing and liver protecting medicine prepared with cassia seed extract |
| 03/01/2006 | CN1739595A Dangshen oral liquid |
| 03/01/2006 | CN1739592A Externally applied medicine for treating toothache |
| 03/01/2006 | CN1739575A Solid and liquid attapulgite prepn for treating digestive tract diseases |
| 03/01/2006 | CN1739550A Polycinnamic alcohol injection and its prepn |
| 03/01/2006 | CN1739536A Compound prepn containing monopotassium glycyrrhizunate and its prepn and application |
| 03/01/2006 | CN1739534A Compound medicine prepn of ginseng stem and leaf total saponin and propolis total flavone for treating gastropathy |
| 03/01/2006 | CN1739532A American ginseng-gynostemma pentaphylla total saponin prepn |
| 03/01/2006 | CN1739526A Prepn process of oral slowly-releasing oleanolic acid |
| 03/01/2006 | CN1739525A Nanometer partical administration system of prostaglandin E1 coated with polyglycol derived phospholipid |
| 03/01/2006 | CN1739521A Application of pyrimidone compounds in preparing medicine |
| 03/01/2006 | CN1739507A Medicine composition for treating mixed infectious disease |
| 03/01/2006 | CN1739500A (-)-epigallocatechin gallate-magnesium complex solid dispersion and its prepn and application |
| 03/01/2006 | CN1739499A (-)-epigallocatechin gallate solid dispersion and its prepn and application |
| 03/01/2006 | CN1739495A Freeze dried tiopronin powder for injection and its prepn |
| 03/01/2006 | CN1243770C Neurotrophic growth factor |
| 03/01/2006 | CN1243753C Substituted 3,4-dihydro-pyrimido[1,2-A] pyrimidines and 3,4-dihydropyrazino [1,2-A] pyrimidines |
| 03/01/2006 | CN1243751C Piperidine compounds as anti-allergic medicine |
| 03/01/2006 | CN1243749C Benzimidazole derivatives |
| 03/01/2006 | CN1243724C Amide derivatives which are useful as cell factor inhibitors |
| 03/01/2006 | CN1243557C Medicine against liver fibrillation |
| 03/01/2006 | CN1243547C New formulation |
| 03/01/2006 | CN1243546C Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 03/01/2006 | CN1243542C Composition comprising free amino acids |
| 02/28/2006 | US7005553 such as 2-nitrophenol by reacting 3-hydroxy-4-methoxybenzophenone with alkyl nitrate in presence of regioselective acid catalyst (sulfuric acid) |
| 02/28/2006 | US7005438 Pharmaceutically active isoindoline derivatives |
| 02/28/2006 | US7005436 Heterocyclo inhibitors of potassium channel function |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | US7005431 Imidazo-triazine derivatives as ligands for gaba receptors |
| 02/28/2006 | US7005408 Anhydrous warming, non- toxic and nonirritating lubricating compositions containing polyhydric alcohols and an insulating agent. The invention also relates to methods of using such compositions for lubrication, administration of active |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/23/2006 | WO2006019960A1 Colostrum-based treatment for irritable bowel syndrome |
| 02/23/2006 | WO2006019037A1 Method of judging liver fibrosis stage |
| 02/23/2006 | WO2006018698A2 Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract |
| 02/23/2006 | WO2006018185A2 Dihydropteridinones for the treatment of cancer diseases |
| 02/23/2006 | WO2005026164A8 Pharmacologically active imidazo[4,5-c]pyridines |
| 02/23/2006 | US20060041009 Pharmaceutical compound containing silymarin and carbopol, production method thereof and use of same as a regenerator of tissue and pancreatic cells with endogenous secretion damaged by diabetes mellitus |
| 02/23/2006 | US20060040992 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 02/23/2006 | US20060040984 Novel piperidine derivatives for use in the treatment of chemokine medicated disease states |
| 02/23/2006 | US20060040963 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/23/2006 | US20060040957 Bicyclic pyrimidine matrix metalloproteinase inhibitors |
| 02/23/2006 | US20060040945 Annellated pyrrole compounds as proton pump inhibitors for treating ulcer |
| 02/23/2006 | US20060040933 Antiinflammatory agents |
| 02/23/2006 | US20060040905 Formulation of nefopam and its use in the treatment of pain |
| 02/23/2006 | US20060040876 Modulation of peroxisome proliferator-activated receptors |
| 02/23/2006 | US20060040005 Administering extract or lyophilized extract or at least one bioactive fraction obtained from the plant Woodfordia fruticosa along with one or more pharmaceutically acceptable additives/carriers for treating ulcer caused by the conditions such as stress induced ulcer, peptic ulcer |
| 02/23/2006 | US20060039959 Film-Shaped Mucoadhesive Administration Forms For Administering Cannabis Agents |
| 02/23/2006 | US20060039953 Water soluble polymer such as pullulan and an antimicrobial effective amount of thymol, methyl salicylate, eucalyptol and/or menthol; killing the plaque-producing germs that cause dental plaque, gingivitis and bad breath |
| 02/23/2006 | US20060039918 Stress proteins and peptides and methods of use thereof |
| 02/23/2006 | US20060039903 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 02/23/2006 | CA2576291A1 Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract |
| 02/23/2006 | CA2575787A1 Dihydropteridinones for the treatment of cancer diseases |